TR201906742T4 - Tıbbi bir ürün ve tedavi. - Google Patents

Tıbbi bir ürün ve tedavi. Download PDF

Info

Publication number
TR201906742T4
TR201906742T4 TR2019/06742T TR201906742T TR201906742T4 TR 201906742 T4 TR201906742 T4 TR 201906742T4 TR 2019/06742 T TR2019/06742 T TR 2019/06742T TR 201906742 T TR201906742 T TR 201906742T TR 201906742 T4 TR201906742 T4 TR 201906742T4
Authority
TR
Turkey
Prior art keywords
ibuprofen
paracetamol
medicine
patients
moderate
Prior art date
Application number
TR2019/06742T
Other languages
English (en)
Turkish (tr)
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201906742(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of TR201906742T4 publication Critical patent/TR201906742T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2019/06742T 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi. TR201906742T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14

Publications (1)

Publication Number Publication Date
TR201906742T4 true TR201906742T4 (tr) 2019-05-21

Family

ID=42106693

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2019/06742T TR201906742T4 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi.
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi

Country Status (29)

Country Link
US (1) US20110166234A1 (enExample)
EP (1) EP2341900B1 (enExample)
JP (1) JP2012505830A (enExample)
KR (1) KR20110112279A (enExample)
CN (1) CN102215835A (enExample)
AU (1) AU2009304002B9 (enExample)
BR (1) BRPI0914086A2 (enExample)
CA (1) CA2735834C (enExample)
CH (1) CH702339B1 (enExample)
CL (1) CL2011000678A1 (enExample)
CO (1) CO6341553A2 (enExample)
CY (1) CY1122198T1 (enExample)
DK (1) DK2341900T3 (enExample)
ES (1) ES2725151T3 (enExample)
GB (1) GB2476418B (enExample)
HR (1) HRP20190891T1 (enExample)
HU (1) HUE043063T2 (enExample)
LT (1) LT2341900T (enExample)
MA (1) MA32635B1 (enExample)
MX (1) MX340662B (enExample)
MY (1) MY153932A (enExample)
NZ (1) NZ591496A (enExample)
PL (1) PL2341900T3 (enExample)
PT (1) PT2341900T (enExample)
RU (1) RU2487707C2 (enExample)
SI (1) SI2341900T1 (enExample)
TR (2) TR201906742T4 (enExample)
WO (1) WO2010044681A1 (enExample)
ZA (1) ZA201101752B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2381794T3 (es) 2004-07-07 2012-05-31 Aft Pharmaceuticals Limited Una composición de combinación que comprende ibuprofeno y paracetamol
HRP20191489T1 (hr) 2010-11-04 2019-11-15 Aft Pharmaceuticals Ltd Kombinirani sastav
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
EP3651721B1 (en) 2017-07-10 2024-09-04 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
ES2381794T3 (es) * 2004-07-07 2012-05-31 Aft Pharmaceuticals Limited Una composición de combinación que comprende ibuprofeno y paracetamol
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
RU2487707C2 (ru) 2013-07-20
EP2341900A1 (en) 2011-07-13
PT2341900T (pt) 2019-05-14
MX340662B (es) 2016-07-20
ES2725151T3 (es) 2019-09-19
ZA201101752B (en) 2012-02-29
MA32635B1 (fr) 2011-09-01
LT2341900T (lt) 2019-04-10
WO2010044681A1 (en) 2010-04-22
JP2012505830A (ja) 2012-03-08
CY1122198T1 (el) 2020-11-25
CA2735834A1 (en) 2010-04-22
EP2341900B1 (en) 2019-02-20
DK2341900T3 (da) 2019-05-20
GB2476418B (en) 2013-04-24
AU2009304002B2 (en) 2013-04-18
HUE043063T2 (hu) 2019-07-29
MY153932A (en) 2015-04-15
CN102215835A (zh) 2011-10-12
SI2341900T1 (sl) 2019-06-28
AU2009304002B9 (en) 2014-06-26
AU2009304002A1 (en) 2010-04-22
NZ591496A (en) 2012-12-21
CL2011000678A1 (es) 2011-09-23
GB201105249D0 (en) 2011-05-11
HRP20190891T1 (hr) 2019-07-12
RU2011111792A (ru) 2012-11-27
BRPI0914086A2 (pt) 2020-01-21
KR20110112279A (ko) 2011-10-12
CA2735834C (en) 2017-05-16
GB2476418A (en) 2011-06-22
CO6341553A2 (es) 2011-11-21
MX2011003928A (es) 2011-08-12
CH702339B1 (de) 2016-06-15
TR201102810T2 (tr) 2011-05-23
PL2341900T3 (pl) 2019-08-30
US20110166234A1 (en) 2011-07-07
EP2341900A4 (en) 2012-02-29

Similar Documents

Publication Publication Date Title
JP7590803B2 (ja) 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
KR20200055067A (ko) 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올
TR201906742T4 (tr) Tıbbi bir ürün ve tedavi.
Campbell et al. Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains.
Oh et al. Comparative analysis of intra-articular injection of steroid and/or sodium hyaluronate in adhesive capsulitis: prospective, double-blind, randomized, placebo-controlled study
US20100226972A1 (en) Transdermal pain gel
MX2013005113A (es) Una composicion combinada.
Kumai et al. Short-term efficacy and safety of hyaluronic acid injection for plantar fasciopathy
RU2616520C2 (ru) Лечение симптомов, связанных с гастропарезом у женщин
Rather et al. Comparaison of efficacy and safety of fentanyl transdermal patch with Oral ketorolac for pain Management in dry Socket: A randomized clinical trial
US20140037718A1 (en) Transdermal pain gel
Yancey et al. Caffeine as an analgesic adjuvant for acute pain in adults
Ewald et al. Screening for developmental dysplasia of the hip in newborns
Byun et al. Effects of repeated steroid injection at subacromial bursa with different interval
JP2014530249A5 (enExample)
WO2000050028A1 (en) Compositions for the treatment of pain
Davis Managing painful conditions in the pharmacy
Harnphadungkit et al. Efficacy of 0.0125% Capsaicin Patch at Acupuncture Point for Pain Relief in Knee Osteoarthritis: A Randomized Controlled Trial
Gosikonda et al. Role of viscosupplementation in the management of primary osteoarthritis knee
Nataraj et al. Evaluation of efficacy and safety of intra-articular hylan GF 20 injection in knee osteoarthritis in patients with repeat injection
UA136611U (uk) Меновазин вішфа
Allison Treatment of plantar fasciitis by low-Dye taping and iontophoresis–short-term results of a double blinded, randomised, placebo controlled clinical trial of dexamethasone and acetic acid.
O'Mathúna Prolotherapy for Chronic Musculoskeletal Pain
MOLAR Dissertation Submitted to Maharashtra University of Health Sciences, Nashik In the Partial Fulfillment of Regulations for the Award of the Degree of
WO2016092377A2 (ru) Композиция, содержащая глюкозамин, фруктобарат кальция и витамин d для лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов, её применение и способ лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов и позвоночника